Taurine
Taurine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Long COVID。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
16 项
全球在招研究
3 项
已进入 III/IV 期
7 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- University of Alberta
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Chinese University of Hong Kong
- Shandong Cancer Hospital and Institute
- Hospital de Clinicas de Porto Alegre
- Louisiana State University and A&M College
- York University
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
中国、中国香港、Brazil、加拿大、美国、Poland、Mexico
正在招募患者的 Taurine 研究
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
II 期招募中中国NCT07029178Butyrate and Taurine for Chronic Postsurgical Pain in Adult Cardiac Surgical Patients
不适用招募中中国香港NCT07144033Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury
I 期 / II 期招募中中国NCT06847555Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes
II 期招募中BrazilNCT04874012Taurine Supplementation in Long COVID
II 期 / III 期招募中加拿大NCT06721949Near-Infrared Spectroscopy, Acute Taurine Supplementation, and Isolated Muscular Endurance and Fatigue Resistance in Young Healthy Adults
不适用招募中美国NCT07654946Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
不适用招募中加拿大NCT07312409Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
IV 期招募中美国NCT06269627Effects of Energy Drinks on Cardiovascular Endpoints
IV 期招募中美国NCT07212803Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
II 期招募中美国NCT07060638Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
不适用招募中中国NCT06128252TCP-600 Supplementation and Performance Response in Professional Football Players
不适用招募中PolandNCT07710547Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
不适用招募中MexicoNCT07487623Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
II 期招募中中国NCT07567742Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
I 期招募中美国NCT07204977Daily Amino Acid Supplementation for People With Parkinson's Disease
不适用招募中美国NCT07115563
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。